At scheduled 3- and 6-month follow-up visits between April and July 2020, participants were given a three-month supply of PrEP medication and an oral OraQuick In-Home HIV Test (HIV self-test; HIVST) kit [14] to support PrEP use during the lockdown. Participants received an orientation to the HIVST and reviewed instructions for use with the study staff. They were asked to send the study staff a photo or text of their HIVST results. We did not provide incentives to study participants for using the HIV self-test kits and returning their test results. Research assistants working remotely conducted participant follow-up interviews, including the COVID-19 module by telephone, to maintain physical distancing. Participants received protocol-specified compensation in Kenyan shillings equivalent to $5 for scheduled follow-up interviews.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.